Neuland Laboratories posts blockbuster FY26 performance

Actio Biosciences launches Phase 1b/2 trial for ultra-rare pediatric epilepsy therapy

The company also confirmed that ABS-1230 has been accepted into the U.S. Food and Drug Administration’s Rare Disease Evidence Principles (RDEP) process

Computational tool ‘Renoir’ to decode cell communication in complex tissues

IIT Kanpur team has developed computational framework to map how cell signals influence gene activity across tissues

Wockhardt hosts Mother’s Day walkathon to promote women’s health and wellness

Women’s wellness initiative promoted preventive healthcare, fitness, and self-care awareness across the Mira Bhayandar community

JB Chemicals reports muted Q4 FY26 as integration resets business

The CDMO segment saw a 22% decline in Q4 due to a strong base in the prior year

Moderna’s mRNA flu vaccine outperforms standard shot in Phase 3 trial

NEJM study shows strong protection across strains

Dabur profit jumps 16% as FMCG growth gains pace

Hair care & quick commerce shine

Cirena licenses Agilent RNA purification tech to unlock high-purity long RNA for genome editing

The agreement targets a long-standing technical hurdle in the field: maintaining chemical purity as RNA constructs extend beyond 100 nucleotides

Industrial AI takes center stage at ARC Industry Leadership India Forum 2026

The event will bring together industrial leaders, technology providers, and policymakers to discuss real-world Industrial AI applications in Bangalore

Bayer strikes $2.45 billion deal for breakthrough blindness drug developer Perfuse Therapeutics

The acquisition gives Bayer full rights to PER-001, an experimental therapy now in Phase II clinical trials for Glaucoma and Diabetic Retinopathy